Abstract:Advancing age leads to an accumulation of senescent endothelial cells (ECs) within arteries. Senescent cells have undergone permanent cell cycle arrest, are pro‐oxidative and pro‐inflammatory, and therefore represent a likely cause of age‐related EC dysfunction. Yet, the molecular mechanisms and physiological consequences of EC senescence remain incompletely understood. Telomeres are repeat DNA sequences that cap chromosomes. Telomeres shorten with each cell division and are highly susceptible to oxidative damage. When telomeres become critically short or damaged, they become uncapped, which activates the DNA damage response and leads to cellular senescence. Here, we tested the hypothesis that aging results in EC telomere uncapping that induces senescence, leading to physiological hallmarks of aging. To assess whether aging results in EC telomere uncapping, we compared ECs from young (~3 mo) and old (~27 mo) mice. Aging resulted in ~4‐fold greater EC telomere uncapping (p<0.001, Figure 1A). To determine if EC telomere uncapping induces senescence, we deleted the telomere capping protein, TRF2, in ECs of young (~3.5mo) mice (TRF2‐ecKO). Compared to wildtype (WT) littermate controls, TRF2‐ecKO mice had a ~78% reduction in TRF2 gene expression (p<0.0001). TRF2 deletion reduced EC division by ~47% (p<0.0001, Figure 1B), indicative of senescence. To examine the physiological consequences of EC senescence, we examined hallmarks of vascular aging including perfused microvascular density and endothelium‐dependent dilation (EDD). TRF2‐ecKO mice had an ~18% reduction in perfused mesenteric microvessels between 5‐25 µM (p<0.001, Figure 1C). Likewise, TRF2‐ecKO displayed ~26% reduction in mesenteric artery EDD compared to WT mice (p<0.05, Figure 1D). Furthermore, TRF2‐ecKO arterial EDD was ameliorated by the superoxide scavenger, TEMPOL (p>0.05, Figure 1D). Endothelium‐independent dilation to the exogenous nitric oxide donor sodium nitroprusside was not different between WT and TRF2‑ecKO mice (p>0.05). These data suggest EC telomere uncapping leads to senescence that reduces perfused microvascular density, and to elevated oxidative stress that suppresses EDD, similar to advanced age. To assess metabolic and muscle function, we performed an intraperitoneal glucose tolerance test (GTT, 2g/kg body mass) and a forelimb grip strength test. TRF2‐ecKO mice had ~21% greater area under the curve during GTT compared to WT mice (p<0.05, Figure 2A) as well as a ~14% reduction in grip strength (p<0.05, Figure2B). Taken together, these data provide evidence that aging results in EC telomere uncapping that induces senescence and age‐related physiological dysfunction.

Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors

Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients

Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells

Endothelial cell telomere dysfunction induces senescence and results in vascular and metabolic impairments

Endothelial Senescence and the Chronic Vascular Diseases: Challenges and Therapeutic Opportunities in Atherosclerosis

Oxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells

Application of Oxidative Stress to a Tissue-Engineered Vascular Aging Model Induces Endothelial Cell Senescence and Activation

Replicative senescence promotes prothrombotic responses in endothelial cells: Role of NADPH oxidase- and cyclooxygenase-derived oxidative stress

Factors and Pathways Modulating Endothelial Cell Senescence in Vascular Aging

Senescence of endothelial cells promotes phenotypic changes in adventitial fibroblasts: possible implications for vascular aging

Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis

New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death

Replicative Endothelial Cell Senescence May Lead to Endothelial Dysfunction by Increasing the BH2/BH4 Ratio Induced by Oxidative Stress, Reducing BH4 Availability, and Decreasing the Expression of eNOS

Cellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy

Understanding the Intricacies of Cellular Senescence in Atherosclerosis: Mechanisms and Therapeutic Implications

Aging results in endothelial cell telomere uncapping that induces senescence and physiological dysfunction

Cellular and Molecular Determinants of Arterial Aging

Targeting vascular senescence in cardiovascular disease with aging

Endothelial Cell Senescence and Age-Related Vascular Diseases

Abstract 100: Omics Strategies To Identify Senescent Cells Mediating Extracellular Matrix Remodeling During Vascular Disease

Abstract 285: Oxidized Low Density Lipoprotein and Angiotensin II Causes Vascular Senescence Via AT1R Signal-mediate Mitochondrial Fission